ACHV | | Achieve Life Sciences, Inc. - Common Shares | | | 1.43% up -8.16% 9.59 | | + Pharmaceutical , Disease: Addictions - Tobacco | + My List |
ACRX | | AcelRx Pharmaceuticals, Inc. - Common Stock | | | 0 | | + Pharmaceutical , Medicine
Last highlighted: Form 8-K: Results of Operations and Financial Condition On January 14, 2021, AcelRx Pharmaceuticals issued a press re.. $ACRX https://t.co/85kZEX2ul8 | + My List |
ADMS | | Adamas Pharmaceuticals, Inc. - Common Stock | | | 0.00% 0 | | + Medicine, Disease: Neurology/Alzheimer/Parkinson's, Pharmaceutical
| + My List |
ADXN | | Addex Therapeutics Ltd - American Depositary Shares | | | -1.69% up -12.53% 10.84 | | + Medicine, Disease: Neurology/Alzheimer/Parkinson's, Pharmaceutical
| + My List |
AERI | | Aerie Pharmaceuticals, Inc. - Common Stock | | | 8.46% 8.46% 0 | | + Disease: Eye , Medicine, Pharmaceutical
Last highlighted: Alert [Press/News Current Report] / Form 8-K filed with the SEC $AERI AERIE PHARMACEUTICALS INC https://t.co/jhemDQoMVR | + My List |
AIKI | | AIkido Pharma Inc. - Common Stock | | | 0 | | + Cancer fight, Pharmaceutical , Medicine
Last highlighted: #AIKI SEC report: AIkido Pharma Inc. Current report, item 8.01 SEC Filing Form 8-K filed by AIkido Pharma Inc. -- SEC File Number 211098058 | + My List |
AKER | | Akers Biosciences Inc. - Common Stock | | | 0.00% 0 | | + Medicine, Pharmaceutical , Immunology, Cancer fight
| + My List |
ANIP | | ANI Pharmaceuticals, Inc. - Common Stock | | | 8.08% 8.08% 0 | | + Generic, Pharmaceutical , Medicine
| + My List |
AQST | | Aquestive Therapeutics, Inc. - Common Stock | | | -6.92% up -7.44% 0.52 | | + Medicine, Pharmaceutical
| + My List |
ARDS | | Aridis Pharmaceuticals Inc. - Common Stock | | | -15.83% -15.83% 0 | | + Disease: Infectious, Pharmaceutical , Medicine
| + My List |
ASLN | | ASLAN Pharmaceuticals Limited - American Depositary Shares | | | 0 | | + Country: Singapore, Pharmaceutical , Biopharma, Immunology, Medicine
Last highlighted: $ASLN / ASLAN Pharmaceuticals files form 6-K https://t.co/rm8jqdBSsq | + My List |
AUPH | | Aurinia Pharmaceuticals Inc - Common Shares | | | -0.36% down 10.39% -10.75 | | + Pharmaceutical , Immunology, Country: Canada
Last highlighted: FORM 10-Q [Quarterly Report] recently SEC filed. $AUPH #AuriniaPharmaceuticals Inc. Aurinia Pharmaceuticals Inc https://t.co/ei2FxR7sZR | + My List |
AVCO | | Avalon GloboCare Corp. - Common Stock | | | 0 | | + Cancer fight, Medicine, Immunology, Pharmaceutical
Last highlighted: #AVCO SEC report: Avalon GloboCare Corp. Current report, items 1.01 and 9.01 SEC Filing Form 8-K filed by Avalon GloboCare Corp. -- SEC File Number 211089336 | + My List |
BIMI | | BOQI International Medical Inc. - Common Stock | | | -7% up -10% 3 | | + Country: China, Medicine, Pharmaceutical
| + My List |
CMPI | | Checkmate Pharmaceuticals, Inc. - Common Stock | | | 327.57% up 326.75% 0.81999999999999 | | + Cancer fight, Medicine, Pharmaceutical
Last highlighted: #CMPI SEC report: Checkmate Pharmaceuticals, Inc. Current report, items 7.01 and 9.01 SEC Filing Form 8-K filed by Checkmate Pharmaceuticals, Inc. -- SEC File Number 211142205 | + My List |
CNST | | Constellation Pharmaceuticals, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight, Medicine, Pharmaceutical
| + My List |
CPRX | | Catalyst Pharmaceuticals, Inc. - Common Stock | | | 4.65% up -7.5% 12.15 | | + Pharmaceutical , Medicine
Last highlighted: #CPRX SEC report: CATALYST PHARMACEUTICALS, INC. Initial statement of beneficial ownership of securities SEC Filing Form 3 filed by CATALYST PHARMACEUTICALS, INC. -- SEC File Number | + My List |
CRNX | | Crinetics Pharmaceuticals, Inc. - Common Stock | | | 2.65% down 7.93% -5.28 | | + Pharmaceutical , Disease: Endocrine disease, Medicine
Last highlighted: #CRNX SEC report: Crinetics Pharmaceuticals, Inc. Automatic shelf registration statement of securities of well-known seasoned issuers SEC Filing Form S-3ASR filed by Crinetics Pharmaceuticals, Inc. -- SEC File Number 211161145 | + My List |
CRVS | | Corvus Pharmaceuticals, Inc. - Common Stock | | | up -7.14% 7.14 | | + Medicine, Immunology, Pharmaceutical
| + My List |
CTXR | | Citius Pharmaceuticals, Inc. - Common Stock | | | up -12.75% 12.75 | | + Pharmaceutical , Medicine
Last highlighted: #CTXR SEC report: Citius Pharmaceuticals, Inc. Notice of Effectiveness SEC Filing Form EFFECT filed by Citius Pharmaceuticals, Inc. -- SEC File Number 211081579 | + My List |
CTXRW | | Citius Pharmaceuticals, Inc. - Warrant | | | 0 | | + Pharmaceutical , Medicine
| + My List |
CYCC | | Cyclacel Pharmaceuticals, Inc. - Common Stock | | | 2.21% down 7.75% -5.54 | | + Biotechnology, Biopharma, Pharmaceutical , Medicine, Gene and cell - Bad infrastructure | + My List |
DRNA | | Dicerna Pharmaceuticals, Inc. - Common Stock | | | 0.00% 0 | | + Biopharma, Pharmaceutical , RNA, Medicine
Last highlighted: $DRNA 📜 Dicerna Pharmaceuticals, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
https://t.co/pVex4DfvFC
30s delayed. | + My List |
DYAI | | Dyadic International, Inc. - Common Stock | | | -7.39% -7.39% 0 | | + Medicine, Biopharma, Pharmaceutical
| + My List |
ENDP | | Endo International plc - Ordinary Shares | | | -45.05% -45.05% 0 | | + Medicine, Pharmaceutical , Country: Ireland, Generic
Last highlighted: Tracking Larry Robbins' Glenview Capital Management Portfolio - Q4 2020 Update | + My List |
ENTX | | Entera Bio Ltd. - Ordinary Shares | | | 6.31% 6.31% 0 | | + Country: Israel, Biotechnology, Pharmaceutical
Last highlighted: $ENTX 📜 SEC Form 6-K filed by Entera Bio Ltd.
https://t.co/dws8IKVGAV
#healthcare | + My List |
ENTXW | | Entera Bio Ltd. - Warrant | | | 0 | | + Country: Israel, Biotechnology, Pharmaceutical
| + My List |
EPIX | | ESSA Pharma Inc. - Common Stock | | | 4.45% down 8.01% -3.56 | | + Pharmaceutical , Country: Canada, Cancer fight
Last highlighted: #EPIX SEC report: ESSA Pharma Inc. [Amend] Statement of acquisition of beneficial ownership by individuals SEC Filing Form SC 13G/A filed by ESSA Pharma Inc. -- SEC File Number 211182253 | + My List |
ETON | | Eton Pharmaceuticals, Inc. - Common Stock | | | -1.69% up -7.32% 5.63 | | + Medicine, Pharmaceutical
| + My List |
EVOK | | Evoke Pharma, Inc. - Common Stock | | | -55.4% -55.4% 0 | | + Pharmaceutical , Medicine, Disease: Gastrointestinal
Last highlighted: FORM 8-K [Press/News Current Report] recently SEC filed. $EVOK Evoke Pharma Inc https://t.co/fwtsPe3b5z | + My List |
EYPT | | EyePoint Pharmaceuticals, Inc. - Common Stock | | | 5.17% up -9.76% 14.93 | | + Pharmaceutical , Disease: Eye , Medicine, Biopharma
Last highlighted: #EYPT SEC report: EyePoint Pharmaceuticals, Inc. Current report, items 2.02 and 9.01 SEC Filing Form 8-K filed by EyePoint Pharmaceuticals, Inc. -- SEC File Number 211142305 | + My List |
FBIO | | Fortress Biotech, Inc. - Common Stock | | | -6.73% up -8.65% 1.92 | | + Pharmaceutical , Biopharma, Biotechnology, Medicine
| + My List |
FUSN | | Fusion Pharmaceuticals Inc. - Common Shares | | | -32.31% -32.31% 0 | | + Pharmaceutical , Country: Canada, Medicine, Radiotherapy, Cancer fight
| + My List |
HRTX | | Heron Therapeutics, Inc. - Common Stock | | | -3.23% up -18.63% 15.4 | | + Medicine, Pharmaceutical
| + My List |
HUGE | | FSD Pharma Inc. - Class B Subordinate Voting Shares | | | -8.91% down -4.95% -3.96 | | + Pharmaceutical , Medicine
| + My List |
ICPT | | Intercept Pharmaceuticals, Inc. - Common Stock | | | 0.48% up -9.64% 10.12 | | + Pharmaceutical , Medicine, Biopharma, Disease: Liver
Last highlighted: #ICPT SEC report: INTERCEPT PHARMACEUTICALS, INC. Statement of changes in beneficial ownership of securities SEC Filing Form 4 filed by INTERCEPT PHARMACEUTICALS, INC. -- SEC File Number | + My List |
ITRM | | Iterum Therapeutics plc - Ordinary Share | | | 0 | | + Pharmaceutical , Medicine, Disease: Infectious
| + My List |
KALV | | KalVista Pharmaceuticals, Inc. - Common Stock | | | -1.25% up -13.4% 12.15 | | + Pharmaceutical , Medicine
Last highlighted: #KALV SEC report: KalVista Pharmaceuticals, Inc. Annual report [Section 13 and 15(d), not S-K Item 405] SEC Filing Form 10-K filed by KalVista Pharmaceuticals, Inc. -- SEC File Number 211087997 | + My List |
KMDA | | Kamada Ltd. - Ordinary Shares | | | -3.52% -3.52% 0 | | + Biopharma, Pharmaceutical , Medicine
Last highlighted: #KMDA SEC report: KAMADA LTD Report of foreign issuer [Rules 13a-16 and 15d-16] SEC Filing Form 6-K filed by KAMADA LTD -- SEC File Number 211161938 | + My List |
KNSA | | Kiniksa Pharmaceuticals, Ltd. - Class A Common Stock | | | -0.37% up -7.06% 6.69 | | + Pharmaceutical , Biopharma, Medicine
Last highlighted: #KNSA SEC report: Kiniksa Pharmaceuticals, Ltd. Current report, items 2.02 and 9.01 SEC Filing Form 8-K filed by Kiniksa Pharmaceuticals, Ltd. -- SEC File Number 211138062 | + My List |
KPTI | | Karyopharm Therapeutics Inc. - Common Stock | | | up -10.02% 10.02 | | + Cancer fight, Disease: Oncology, Pharmaceutical , Medicine
Last highlighted: #KPTI SEC report: Karyopharm Therapeutics Inc. Statement of changes in beneficial ownership of securities SEC Filing Form 4 filed by Karyopharm Therapeutics Inc. -- SEC File Number | + My List |
MACK | | Merrimack Pharmaceuticals, Inc. - Common Stock | | | -2.24% down 7.72% -9.96 | | + Pharmaceutical , Cancer fight, Medicine
| + My List |
MBRX | | Moleculin Biotech, Inc. - Common Stock | | | -7.58% -7.58% 0 | | + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious
Last highlighted: #MBRX SEC report: Moleculin Biotech, Inc. Statement of changes in beneficial ownership of securities | + My List |
MTP | | Midatech Pharma PLC - American Depositary Shares | | | 0 | | + Country: Greate Britain, Medicine, 3D, Pharmaceutical
Last highlighted: $MTP 📜 SEC Form 6-K filed by Midatech Pharma PLC
https://t.co/bXrzkJUXsF
#majorpharmaceuticals #healthcare | + My List |
NEOS | | Neos Therapeutics, Inc. - Common Stock | | | 0.00% 0 | | + Medicine, Pharmaceutical , Disease: Neurology/Alzheimer/Parkinson's
| + My List |
OCUP | | Ocuphire Pharma, Inc. - Common Stock | | | -4.07% -4.07% 0 | | + Disease: Eye , Biopharma, Medicine, Pharmaceutical
Last highlighted: $OCUP 📜 Ocuphire Pharma, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
https://t.co/xMAN0ucl8b
15s delayed. | + My List |
OPNT | | Opiant Pharmaceuticals, Inc. - Common Stock | | | 0.54% down 20.62% -20.08 | | + Pharmaceutical , Medicine, Alcohol, Cannabis
Last highlighted: #OPNT SEC report: OPIANT PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01 SEC Filing Form 8-K filed by OPIANT PHARMACEUTICALS, INC. -- SEC File Number 211148259 | + My List |
OPTN | | OptiNose, Inc. - Common Stock | | | 1.99% down 9.73% -7.74 | | + Medicine, Disease: Ear/Nose, Pharmaceutical
| + My List |
ORIC | | Oric Pharmaceuticals, Inc. - Common Stock | | | -7.43% -7.43% 0 | | + Pharmaceutical , Medicine, Disease: Oncology, Cancer fight
Last highlighted: #ORIC SEC report: Oric Pharmaceuticals, Inc. Current report, items 8.01 and 9.01 SEC Filing Form 8-K filed by Oric Pharmaceuticals, Inc. -- SEC File Number 211078899 | + My List |
ORMP | | Oramed Pharmaceuticals Inc. - Common Stock | | | -11% -11% 0 | | + Medicine, Pharmaceutical
| + My List |
OSMT | | Osmotica Pharmaceuticals plc - Ordinary Shares | | | 0.00% 0 | | + Pharmaceutical , Women Health, Biopharma
| + My List |
PLXP | | PLx Pharma Inc. - Common Stock | | | -8.25% -8.25% 0 | | + Disease: Gastrointestinal, Medicine, Pharmaceutical
| + My List |
PMVP | | PMV Pharmaceuticals, Inc. - Common Stock | | | 0.37% down 8.23% -7.86 | | + Medicine, Cancer fight, Pharmaceutical
Last highlighted: #PMVP SEC report: PMV Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities SEC Filing Form 4 filed by PMV Pharmaceuticals, Inc. -- SEC File Number | + My List |
PRTK | | Paratek Pharmaceuticals, Inc. - Common Stock | | | 5.26% down 8.33% -3.07 | | + Pharmaceutical , Biopharma, Medicine, Life Sciences
| + My List |
RETA | | Reata Pharmaceuticals, Inc. - Class A Common Stock | | | 2.33% down 7.74% -5.41 | | + Pharmaceutical , Disease: Kidney, Medicine
| + My List |
RSSS | | Research Solutions, Inc - Common Stock | | | -0.95% down 8.65% -9.6 | | + Life Sciences, SaaS, Pharmaceutical
| + My List |
RYTM | | Rhythm Pharmaceuticals, Inc. - Common Stock | | | -0.86% up -8.49% 7.63 | | + Pharmaceutical , Gene and cell, Medicine
Last highlighted: #RYTM SEC report: RHYTHM PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01 SEC Filing Form 8-K filed by RHYTHM PHARMACEUTICALS, INC. -- SEC File Number 211137945 | + My List |
SCPH | | scPharmaceuticals Inc. - Common Stock | | | -2.63% up -10.87% 8.24 | | + Pharmaceutical , Medicine
Last highlighted: $SCPH [15s. delayed] filed form 8-K on July 01, 08:10:00: Item8.01: Other Material Events https://t.co/XvnQaKOhSx | + My List |
SLRX | | Salarius Pharmaceuticals, Inc. - Common Stock | | | 0 | | + Cancer fight, Biotechnology, Medicine, Pharmaceutical
Last highlighted: $SLRX 8-K Salarius Pharmaceuticals (8 Mar, 4:30pm)
📰 Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
https://t.co/AWdEx2wgvD
#SLRX #8K #SalariusPharmaceuticals #News | + My List |
TCON | | TRACON Pharmaceuticals, Inc. - Common Stock | | | -1.54% down 13.53% -15.07 | | + Pharmaceutical , Cancer fight, Medicine, Biopharma, Disease: Oncology
| + My List |
TENX | | Tenax Therapeutics, Inc. - Common Stock | | | 0 | | + Pharmaceutical , Medicine
Last highlighted: #TENX SEC report: TENAX THERAPEUTICS, INC. [Amend] General statement of acquisition of beneficial ownership SEC Filing Form SC 13D/A filed by TENAX THERAPEUTICS, INC. -- SEC File Number 211083528 | + My List |
TXMD | | TherapeuticsMD, Inc. - Common Stock | | | -6.39% up -11.78% 5.39 | | + Women Health, Pharmaceutical , Medicine - Bad infrastructure Last highlighted: #TXMD SEC report: TherapeuticsMD, Inc. Current report, items 2.02, 7.01, and 9.01 SEC Filing Form 8-K filed by TherapeuticsMD, Inc. -- SEC File Number 211142293 | + My List |
VSPRU | | Vesper Healthcare Acquisition Corp. - Unit | | | 0.00% 0 | | + Acquisitions/Investing, Healthcare, Medicine, Pharmaceutical
Last highlighted: $VSPRU [15s. delayed] filed form 8-K/A on April 27, 08:49:59: Item8.01: Other Material Events https://t.co/lO6rnv4ril | + My List |
XFOR | | X4 Pharmaceuticals, Inc. - Common Stock | | | -8.73% -8.73% 0 | | + Cancer fight, Medicine, Pharmaceutical
Last highlighted: #XFOR SEC report: X4 Pharmaceuticals, Inc Current report, item 2.02 SEC Filing Form 8-K filed by X4 Pharmaceuticals, Inc -- SEC File Number 211138073 | + My List |
ZNTL | | Zentalis Pharmaceuticals, Inc. - common stock | | | 4.73% down 18.04% -13.31 | | + Cancer fight, Biology, Pharmaceutical , Medicine
Last highlighted: #ZNTL SEC report: Zentalis Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities SEC Filing Form 4 filed by Zentalis Pharmaceuticals, Inc. -- SEC File Number | + My List |
ZYNE | | Zynerba Pharmaceuticals, Inc. - Common Stock | | | -8% -8% 0 | | + Cannabis, Medicine, Pharmaceutical , Disease: Neuropsychiatric
Last highlighted: #ZYNE SEC report: Zynerba Pharmaceuticals, Inc. Current report, items 8.01 and 9.01 SEC Filing Form 8-K filed by Zynerba Pharmaceuticals, Inc. -- SEC File Number 211089272 | + My List |
CLVR | | Clever Leaves Holdings Inc. - Common Shares | | | -2.31% down 18.46% -20.77 | | + Medicine, Healthcare, Cannabis, Pharmaceutical
| + My List |
CLVRW | | Clever Leaves Holdings Inc. - Warrant | | | 0 | | + Medicine, Cannabis, Pharmaceutical , Healthcare
| + My List |
INM | | InMed Pharmaceuticals Inc. - Common Shares | | | up -15.84% 15.84 | | + Country: Canada, Pharmaceutical , Medicine, Cannabinoid-based
| + My List |
KMPH | | KemPharm, Inc. - Common Stock | | | -7.16% -7.16% 0 | | + Medicine, Pharmaceutical
Last highlighted: #KMPH SEC report: KEMPHARM, INC Current report, items 8.01 and 9.01 SEC Filing Form 8-K filed by KEMPHARM, INC -- SEC File Number 211102850 | + My List |
PHVS | | Pharvaris N.V. - Ordinary Shares | | | -2.65% -2.65% 0 | | + Medicine, Pharmaceutical
Last highlighted: $PHVS 📜 SEC Form 6-K filed by Pharvaris N.V.
https://t.co/Ra28QDTJZ3
15s delayed. | + My List |
TERN | | Terns Pharmaceuticals, Inc. - Common Stock | | | 5.23% 5.23% 0 | | + Biopharma, Pharmaceutical , Disease: Liver
Last highlighted: $TERN 8-K Terns Pharmaceuticals (14 Jun, 4:40pm)
📰 Terns Reports Positive Top-line Results from Phase 2a LIFT Study of FXR Agonist TERN-101 in Patients with NASH
https://t.co/wJNwFxLOZw
#TERN #8K #TernsPharmaceuticals #News | + My List |
VRPX | | Virpax Pharmaceuticals, Inc. - Common Stock | | | 5.34% up -7.09% 12.43 | | + Pharmaceutical , Medicine
| + My List |
VSPR | | Vesper Healthcare Acquisition Corp. - Class A Common Stock | | | 0.00% 0 | | + Acquisitions/Investing, Medicine, Pharmaceutical , Healthcare
| + My List |
UPC | | Universe Pharmaceuticals Inc - Ordinary Shares | | | -8.53% -8.53% 0 | | + Country: China, Pharmaceutical , Medicine
| + My List |